Table 2.
Intake of different drugs based on Anatomical Therapeutical Chemical (ATC)-codes in the year before the bariatric surgery in all included patients
| n | Total | Men | Women | p-value |
|---|---|---|---|---|
| 19,901 | 5220 | 14,681 | ||
| Antidepressants | 2367 (12%) | 457 (9%) | 1910 (13%) | < 0.001 |
| Antipsychotics | 641 (3%) | 149 (3%) | 492 (3%) | 0.081 |
| Anxiolytics | 362 (1%) | 71 (1%) | 291 (2%) | 0.004 |
| Antiepileptics | 595 (3%) | 150 (3%) | 445 (3%) | 0.566 |
| Addictive disorders | 51 (0.3%) | 23 (0.4%) | 28 (0.2%) | 0.002 |
| Bone mineralization | 49 (0.2%) | 12 (0.2%) | 37 (0.3%) | 0.782 |
| Non-steroidal antirheumatics | 4319 (22%) | 1092 (21%) | 3227 (22%) | 0.110 |
| Insulin | 339 (2%) | 147 (3%) | 192 (1%) | < 0.001 |
|
Antidiabetics (without insulin) |
1238 (6%) | 479 (9%) | 759 (5%) | < 0.001 |
| Antihypertensives | 376 (2%) | 156 (3%) | 220 (2%) | < 0.001 |
| Diuretics | 591 (3%) | 215 (4%) | 376 (3%) | < 0.001 |
| Peripheral vasodilators | 44 (0.2%) | 18 (0.3%) | 26 (0.2%) | 0.027 |
| Beta blocking agents | 1220 (6%) | 435 (8%) | 785 (5%) | < 0.001 |
| Calcium channel blocker | 444 (2%) | 182 (4%) | 262 (2%) | < 0.001 |
| Renin-angiotensin inhibitors | 2771 (14%) | 1099 (21%) | 1672 (11%) | < 0.001 |
| Lipid-lowering | 1376 (7%) | 572 (11%) | 804 (6%) | < 0.001 |
| Statins | 1,247 (6%) | 516 (10%) | 731 (5%) | < 0.001 |
| Fibrates | 127 (0.6%) | 58 (1.1%) | 69 (0.5%) | < 0.001 |
p-value represents men vs. women